Thursday, May 26, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Zydus Cadila Launches Breast Cancer Treatment Drug Ujvira

Zydus Cadila launches breast cancer treatment drug Ujvira

By PTI
Published: Published Date - 11:51 AM, Mon - 24 May 21
Representational Image Zydus Cadila said HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25 per cent of all breast cancers.

New Delhi: Zydus Cadila on Monday launched Ujvira, a drug used for treatment of breast cancer. The company has launched Trastuzumab Emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective drug for treating both early and advanced HER2 positive breast cancer, under the brand name Ujvira, Zydus Cadila said in a statement.

“In a step that can significantly reduce treatment cost by almost 80 per cent, the drug is being offered at Rs 32,495 for a 100 mg vial. The current MRP of existing Trastuzumab Emtansine drug is Rs 1,59,225 for 100 mg vial. Ujvira will be available in two strengths, 100 mg and 160 mg,” the company added.

Zydus Cadila said HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25 per cent of all breast cancers.

Dr Sharvil Patel, Managing Director, Cadila Healthcare the launch of Ujvira reinforces the innovation capabilities that India has to be able to create complex therapies like ADCs and Zydus’ ongoing commitment to offer breakthroughs backed by science and innovation.

Trastuzumab Emtansine ADC biosimilar is a developmental breakthrough due to its complexity in manufacturing and similarity assays.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • breast cancer treatment
  • HER2 positive breast cancer
  • Trastuzumab Emtansine
  • Ujvira

Related News

  • Pharma industry optimistic about 2022-23 horizon

  • Indian pharma majors to pump in big investments into research

  • India should aim for patent box regime: Industry

  • Registration for teens’ vaccination to begin on CoWIN App from Jan 1

  • Covid vaccine exclusively for adolescents likely

  • Editorial: Boost to vaccination drive

Latest News

  • Ravi Teja’s ‘Rama Rao On Duty’ release postponed

    5 mins ago
  • Adivi Sesh plans to arrange a special screening of ‘Major’ for Pawan Kalyan

    21 mins ago
  • Gyanvapi Mosque case: Varanasi court to hear Muslim side’s plea

    20 mins ago
  • KL Rahul becomes first player to score 600-plus runs in 4 IPL seasons

    36 mins ago
  • 25 killed in Rio de Janeiro police operation

    51 mins ago
  • Politics of victimisation, says Karti on Chinese visa scam case

    1 hour ago
  • Telangana man found dead in hotel room in Delhi’s Mahipalpur

    1 hour ago
  • Huawei CEO India approaches Delhi HC challenging LOC against him

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam